Skip to main content
Equibles

ALPS ADVISORS INC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1376113 Denver, CO
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$243,592
+$11,982 QoQ
Shares Held
94,051
+24.7% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 179 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. AVXL ranks #110 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 315,335 $17,680,833
2
62,523 $8,298,677
3 CGON
CG Oncology, Inc.
 89,218 $6,338,938
4 XENE
Xenon Pharmaceuticals Inc.
 97,610 $5,891,739
5 ORKA
Oruka Therapeutics, Inc.
 61,014 $5,806,702
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 55,281 $5,388,791
7 TVTX
Travere Therapeutics, Inc.
 93,981 $5,339,060
8 DFTX
Definium Therapeutics, Inc.
 110,388 $5,192,651

All Filings in AVXL

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $243,592 94,051
2026-03-31 $231,610 75,443
2025-12-31 $261,165 73,361
2025-09-30 $343,593 38,606
2025-06-30 $424,857 46,080
2025-03-31 $516,687 60,220
2024-12-31 $736,398 68,566
2024-09-30 $363,400 63,979
2024-06-30 $278,726 66,049
2024-03-31 $294,777 57,913
2023-12-31 $522,579 56,131
2023-09-30 $395,954 60,451
2023-06-30 $483,084 59,420
2023-03-31 $440,609 51,413
2022-12-31 $490,076 52,924
2022-09-30 $438,600 42,500
2022-06-30 $459,719 45,926
2022-03-31 $963,700 78,286
2021-12-31 $1,525,434 87,972